SAB Biotherapeutics Inc. (SABS)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

4.08

1.24%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	2.24M	23.90M	60.88M	55.24M	3.44M
Cost of Revenue	3.75M	3.29M	1.65M	-	-
Gross Profit	-1.51M	20.61M	59.22M	55.24M	3.44M
Operating Income	-38.08M	-28.92M	-13.39M	20.56M	-8.67M
Interest Income	584.97K	71.07K	23.11K	26.13K	113.13K
Pretax Income	-42.19M	-18.72M	-17.14M	20.12M	-8.99M
Net Income	-42.19M	-18.74M	-17.44M	20.12M	-9.42M
Selling & General & Admin	20.05M	16.38M	17.09M	6.77M	4.10M
Research & Development	16.52M	36.44M	57.18M	27.91M	8.02M
Other Expenses	-	-23.90M	-60.88M	4.00K	2.59K
Operating Expenses	40.31M	28.92M	13.39M	34.68M	12.12M
Interest Expense	315.28K	301.58K	294.46K	469.15K	428.48K
Selling & Marketing Expenses	-3.75M	-	-	-	-
Cost & Expenses	40.31M	28.92M	13.39M	34.68M	12.12M
Income Tax	-	25.63K	299.95K	473.15K	431.07K
Shares Outstanding (Basic)	5.52M	4.35M	2.73M	2.54M	43.47M
Shares Outstanding (Diluted)	5.52M	4.35M	2.73M	2.70M	43.47M
EPS (Basic)	-7.64	-4.31	-6.38	7.92	-0.22
EPS (Diluted)	-7.64	-4.31	-6.38	7.45	-0.22
EBITDA	-38.08M	-15.12M	-15.20M	21.14M	-8.23M
Depreciation & Amortization	3.75M	3.29M	1.65M	548.18K	323.41K